iPS cells used to correct genetic mutations that cause muscular dystrophy

Researchers at the Center for iPS Cell Research and Application , Kyoto University, show that induced pluripotent stem cells can be used to correct genetic mutations that cause Duchenne muscular dystrophy . The research, published in Stem Cell Reports , demonstrates how engineered nucleases, such as TALEN and CRISPR, can be used to edit the genome of iPS cells generated from the skin cells of a DMD patient.

http://ift.tt/1vHHThS